Cyclone 3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Laufzeit: 01.01.2023 - 31.12.2026
imported
Kurzfassung
To determine whether adding abemaciclib to
abiraterone plus prednisonea improves
radiographic progression-free survival (rPFS).
To characterize the safety of adding
abemaciclib to abiraterone plus prednisone
To characterize the PK of abemaciclib when
administered in combination with abiraterone
Beteiligte Einrichtungen
